Zobrazeno 1 - 10 of 84 pro vyhledávání: '"Machlitt-Northen S"'
1
Akademický článek
Long-term safety and tolerability of ambrisentan treatment for pediatric patients with pulmonary arterial hypertension: An open-label extension study.
Autor: Ivy D; Pediatric Cardiology, Children's Hospital Colorado, Aurora, CO, USA., Beghetti M; Pediatric Cardiology Unit, University Children's Hospital HUG, Pulmonary Hypertension Program HUG, University of Geneva, Geneva, Switzerland., Juaneda-Simian E; Pediatric Cardiology, Department of Cardiology, Hospital de Niños de la Santísma Trinidad, Córdoba, Argentina., Ravindranath R; Biostatistics (R&D), GSK, Bangalore, India., Lukas MA; Respiratory/Immunology Clinical Research, GSK, 1250 S Collegeville Rd, Collegeville, Philadelphia, PA, 19426, USA. mary.ann.lukas@gsk.com., Machlitt-Northen S; Clinical Science, GSK Medicines Research Centre, Stevenage, UK., Scott N; Global Safety, GSK, Brentford, Middlesex, UK., Narita J; Pediatrics, Osaka University Graduate School of Medicine, Osaka, Japan., Berger RMF; Center for Congenital Heart Diseases, Pediatric Cardiology, Beatrix Children's Hospital, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Publikováno v: European journal of pediatrics [Eur J Pediatr] 2024 May; Vol. 183 (5), pp. 2141-2153. Date of Electronic Publication: 2024 Feb 16.
Zobrazit plný text záznamu
2
Editorial & Opinion
Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
Autor: Beghetti M; Centre Universitaire de Cardiologie et Chirurgie Cardiaque Pédiatrique, Congenital Heart Center (CHUV et HUG), Geneva, Switzerland., Ivy D; University of Colorado School of Medicine Children's Hospital Colorado, Aurora, CO, USA., Scott N; GlaxoSmithKline, Brentford, UK., Machlitt-Northen S; GlaxoSmithKline, Brentford, UK., Lukas MA; GlaxoSmithKline, Brentford, UK. mary.ann.lukas@gsk.com.
Publikováno v: European journal of pediatrics [Eur J Pediatr] 2023 May; Vol. 182 (5), pp. 2453-2454. Date of Electronic Publication: 2023 Feb 27.
Zobrazit plný text záznamu
3
Akademický článek
The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.
Autor: Ochoa D; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Hercules A; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Carmona M; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Suveges D; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Baker J; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Malangone C; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Lopez I; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Miranda A; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Cruz-Castillo C; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Fumis L; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Bernal-Llinares M; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Tsukanov K; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Cornu H; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Tsirigos K; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Razuvayevskaya O; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Buniello A; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Schwartzentruber J; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Karim M; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Ariano B; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Martinez Osorio RE; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Ferrer J; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Ge X; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Machlitt-Northen S; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK., Gonzalez-Uriarte A; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Saha S; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Tirunagari S; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Mehta C; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Roldán-Romero JM; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Horswell S; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Young S; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Ghoussaini M; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Hulcoop DG; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK., Dunham I; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., McDonagh EM; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
Publikováno v: Nucleic acids research [Nucleic Acids Res] 2023 Jan 06; Vol. 51 (D1), pp. D1353-D1359.
Zobrazit plný text záznamu
4
Akademický článek
Polygenic risk scores for schizophrenia and major depression are associated with socio-economic indicators of adversity in two British community samples.
Autor: Machlitt-Northen S; Department of Biological and Experimental Psychology, Queen Mary University of London, London, UK., Keers R; Department of Biological and Experimental Psychology, Queen Mary University of London, London, UK., Munroe PB; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London, UK., Howard DM; Social, Genetic and Developmental Psychiatry Centre, King's College London, London, UK.; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK., Pluess M; Department of Biological and Experimental Psychology, Queen Mary University of London, London, UK. m.pluess@qmul.ac.uk.
Publikováno v: Translational psychiatry [Transl Psychiatry] 2022 Nov 14; Vol. 12 (1), pp. 477. Date of Electronic Publication: 2022 Nov 14.
Zobrazit plný text záznamu
5
Akademický článek
Polygenic scores for schizophrenia and major depression are associated with psychosocial risk factors in children: evidence of gene-environment correlation.
Autor: Machlitt-Northen S; Department of Biological and Experimental Psychology, Queen Mary University of London, London, UK., Keers R; Department of Biological and Experimental Psychology, Queen Mary University of London, London, UK., Munroe PB; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, London, UK., Howard DM; Social, Genetic and Developmental Psychiatry Centre, King's College London, London, UK.; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh, UK., Trubetskoy V; Department of Psychiatry and Psychotherapy, Universitätsmedizin Berlin Campus Charité Mitte, Berlin, Germany., Pluess M; Department of Biological and Experimental Psychology, Queen Mary University of London, London, UK.
Publikováno v: Journal of child psychology and psychiatry, and allied disciplines [J Child Psychol Psychiatry] 2022 Oct; Vol. 63 (10), pp. 1140-1152. Date of Electronic Publication: 2022 Jul 04.
Zobrazit plný text záznamu
6
Akademický článek
Gene-Environment Correlation over Time: A Longitudinal Analysis of Polygenic Risk Scores for Schizophrenia and Major Depression in Three British Cohorts Studies.
Autor: Machlitt-Northen S; Department of Biological and Experimental Psychology, Queen Mary University of London, London E1 4NS, UK., Keers R; Department of Biological and Experimental Psychology, Queen Mary University of London, London E1 4NS, UK., Munroe PB; Department of Clinical Pharmacology, William Harvey Research Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK., Howard DM; Social, Genetic and Developmental Psychiatry Centre, King's College London, London SE5 8AF, UK.; Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh EH10 5HF, UK., Pluess M; Department of Biological and Experimental Psychology, Queen Mary University of London, London E1 4NS, UK.
Publikováno v: Genes [Genes (Basel)] 2022 Jun 24; Vol. 13 (7). Date of Electronic Publication: 2022 Jun 24.
Zobrazit plný text záznamu
7
Akademický článek
DATA COMMONING IN THE LIFE SCIENCES.
Autor: Priego, Laia Pujol (AUTHOR) Laia.pujol@esade.edu, Wareham, Jonathan (AUTHOR) Jonathan.wareham@esade.edu
Publikováno v: MIS Quarterly. Jun2024, Vol. 48 Issue 2, p491-520. 30p. 4 Diagrams, 5 Charts.
Zobrazit plný text záznamu
8
Akademický článek
Accelerated hit identification with target evaluation, deep learning and automated labs: prospective validation in IRAK1.
Autor: Kamuntavičius, Gintautas1 (AUTHOR) gkamuntavicius@ro5.ai, Prat, Alvaro1 (AUTHOR) aprat@ro5.ai, Paquet, Tanya1 (AUTHOR), Bastas, Orestis1 (AUTHOR), Aty, Hisham Abdel1 (AUTHOR), Sun, Qing2 (AUTHOR), Andersen, Carsten B.2 (AUTHOR), Harman, John2 (AUTHOR), Siladi, Marc E.2 (AUTHOR), Rines, Daniel R.2 (AUTHOR), Flatters, Sarah J. L.1 (AUTHOR) sflatters@ro5.ai, Tal, Roy1 (AUTHOR) rtal@ro5.ai, Norvaišas, Povilas1 (AUTHOR) pnorvaisas@ro5.ai
Publikováno v: Journal of Cheminformatics. 11/14/2024, Vol. 16 Issue 1, p1-18. 18p.
Zobrazit plný text záznamu
9
Akademický článek
Open Targets Platform: supporting systematic drug-target identification and prioritisation.
Autor: Ochoa D; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Hercules A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Carmona M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Suveges D; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Gonzalez-Uriarte A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Malangone C; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Miranda A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Fumis L; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Carvalho-Silva D; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Spitzer M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Baker J; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Ferrer J; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Raies A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Razuvayevskaya O; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Faulconbridge A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Petsalaki E; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Mutowo P; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK., Machlitt-Northen S; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK., Peat G; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., McAuley E; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Ong CK; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Mountjoy E; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Ghoussaini M; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Pierleoni A; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Papa E; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Systems Biology, Biogen, Cambridge, MA 02142, USA., Pignatelli M; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Koscielny G; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK., Karim M; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Schwartzentruber J; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., Hulcoop DG; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK., Dunham I; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK., McDonagh EM; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
Publikováno v: Nucleic acids research [Nucleic Acids Res] 2021 Jan 08; Vol. 49 (D1), pp. D1302-D1310.
Zobrazit plný text záznamu
10
Akademický článek
Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics.
Autor: Ghoussaini M; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Mountjoy E; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Carmona M; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Peat G; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Schmidt EM; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Hercules A; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Fumis L; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Miranda A; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Carvalho-Silva D; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Buniello A; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Burdett T; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Hayhurst J; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Baker J; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Ferrer J; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Gonzalez-Uriarte A; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Jupp S; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Karim MA; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Koscielny G; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK., Machlitt-Northen S; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK., Malangone C; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Pendlington ZM; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Roncaglia P; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Suveges D; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Wright D; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Vrousgou O; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Papa E; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; Systems Biology, Biogen, Cambridge, MA 02142, USA., Parkinson H; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., MacArthur JAL; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Todd JA; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, NIHR Oxford Biomedical Research Centre, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK., Barrett JC; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Schwartzentruber J; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Hulcoop DG; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; GlaxoSmithKline plc, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage SG1 2NY, UK., Ochoa D; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., McDonagh EM; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK., Dunham I; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SA, UK.; Open Targets, Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Hinxton, Cambridgeshire CB10 1SD, UK.
Publikováno v: Nucleic acids research [Nucleic Acids Res] 2021 Jan 08; Vol. 49 (D1), pp. D1311-D1320.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje